Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders
US9724399B2 · kind B2 · utility
3Cited by
1References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 23, 2009 |
| Grant date | Aug 8, 2017 |
| Priority date | — |
| Expiry date | Jun 24, 2031 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of at least one compound comprising the amino acid sequence
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.